Literature DB >> 10633176

Evaluation of thresholds for benomyl- and carbendazim-induced aneuploidy in cultured human lymphocytes using fluorescence in situ hybridization.

K S Bentley1, D Kirkland, M Murphy, R Marshall.   

Abstract

Threshold mechanisms of activity for mutagenic agents have been debated for some time, especially for those substances which induce aneuploidy by inhibiting mitotic spindle function. No observed effect levels (NOELs) or "practical thresholds" have been demonstrated for several aneugens both in vitro and in vivo generally by either counting chromosomes in metaphase preparations or by observing micronuclei. Recently, fluorescence in situ hybridization (FISH) has proven to be a sensitive and useful technique for the assessment of aneuploidy at low concentrations. Using binucleate human lymphocytes coupled with FISH, we have been able to characterize a threshold mechanism of action for two spindle inhibitors, benomyl and its active metabolite, carbendazim. Test chemicals were added 24 h following culture initiation. After a further 20 h, cytochalasin B was added, and cells were harvested 28 h later (72 h post initiation). The distribution of chromosomes between the nuclei of binucleate cells was evaluated by fluorescence microscopy for the simultaneous detection of centromeres labeled with FITC (green) or Cy-3 (red). Six human chromosomes were investigated in pairs (1 and 8, 11 and 18, and X and 17). Abnormalities were classified as chromosome loss (including centromeric positive micronuclei), chromosome gain, non-disjunction, or polyploidy. Dose-response data were generated over a range of closely spaced concentrations at 100 ng/ml intervals. The threshold, defined as the lowest "effect" concentration using statistical methods, was determined for each chromosome. Non-disjunction proved to be the most sensitive endpoint for the detection of aneuploidy occurring at higher frequencies and lower concentrations. Results for the six chromosomes demonstrated similar dose-response data which included a series of concentrations with no statistically significant increase above background, followed by a second range of higher concentrations with a statistically significant, concentration-dependent increase. Nearly equimolar threshold concentrations were determined for benomyl- and carbendazim-induced non-disjunction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10633176     DOI: 10.1016/s1383-5718(99)00165-5

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  6 in total

1.  Simultaneous Confidence Bands for Abbott-Adjusted Quantal Response Models.

Authors:  Brooke E Buckley; Walter W Piegorsch
Journal:  Stat Methodol       Date:  2008-05

2.  In vitro micronucleus assay scored by flow cytometry provides a comprehensive evaluation of cytogenetic damage and cytotoxicity.

Authors:  Steven M Bryce; Jeffrey C Bemis; Svetlana L Avlasevich; Stephen D Dertinger
Journal:  Mutat Res       Date:  2007-03-19       Impact factor: 2.433

3.  Environmentally relevant exposures of male mice to carbendazim and thiram cause persistent genotoxicity in male mice.

Authors:  Bina Rai; Steven Don Mercurio
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-15       Impact factor: 4.223

4.  Seven benzimidazole pesticides combined at sub-threshold levels induce micronuclei in vitro.

Authors:  Sibylle Ermler; Martin Scholze; Andreas Kortenkamp
Journal:  Mutagenesis       Date:  2013-04-01       Impact factor: 3.000

5.  Determination of DNA damage in floriculturists exposed to mixtures of pesticides.

Authors:  J Castillo-Cadena; L E Tenorio-Vieyra; A I Quintana-Carabia; M M García-Fabila; E Ramírez-San Juan; E Madrigal-Bujaidar
Journal:  J Biomed Biotechnol       Date:  2006

6.  Genotoxicity of flubendazole and its metabolites in vitro and the impact of a new formulation on in vivo aneugenicity.

Authors:  David J Tweats; George E Johnson; Ivan Scandale; James Whitwell; Dean B Evans
Journal:  Mutagenesis       Date:  2015-10-06       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.